Please login to the form below

Not currently logged in
Email:
Password:

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.

She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.

DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.

"Deborah's broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma's president and CEO Dr Navneet Puri.

“We look forward to working with Deborah as we continue to build our business and execute on our goals."

13th August 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics